Cargando…

Refining drug administration in a murine model of acute infection with Trypanosoma cruzi

BACKGROUND: In animal research, “refinement” refers to modifications of husbandry or experimental procedures to enhance animal well-being and minimize or eliminate pain and distress. Evaluation of drug efficacy in mice models, such as those used to study Trypanosoma cruzi infection, require prolonge...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulin, Julián Ernesto Nicolás, Bisio, Margarita, García-Bournissen, Facundo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576763/
https://www.ncbi.nlm.nih.gov/pubmed/33094096
http://dx.doi.org/10.1186/s42826-020-00071-z
_version_ 1783598078867013632
author Gulin, Julián Ernesto Nicolás
Bisio, Margarita
García-Bournissen, Facundo
author_facet Gulin, Julián Ernesto Nicolás
Bisio, Margarita
García-Bournissen, Facundo
author_sort Gulin, Julián Ernesto Nicolás
collection PubMed
description BACKGROUND: In animal research, “refinement” refers to modifications of husbandry or experimental procedures to enhance animal well-being and minimize or eliminate pain and distress. Evaluation of drug efficacy in mice models, such as those used to study Trypanosoma cruzi infection, require prolonged drug administration by the oral route (e.g. for 20 consecutive days). However, the orogastric gavage method can lead to significant discomfort, upper digestive or respiratory tract lesions, aspiration pneumonia and even accidental death. The aim of this work was to evaluate the effect of two administration methods (conventional oral gavage vs. a refined method using a disposable tip and automatic pipette) on the efficacy of benznidazole in a murine model of T. cruzi infection. RESULTS: Both administration methods led to a rapid and persistent reduction in parasitaemia. Absence of T. cruzi DNA (evaluated by real-time PCR) in blood, cardiac and skeletal muscle confirmed that treatment efficacy was not influenced by the administration method used. CONCLUSIONS: The proposed refined method for long-term oral drug administration may be a suitable strategy for assessing drug efficacy in mice models of Chagas disease and can be applied to similar murine infection models to reduce animal discomfort.
format Online
Article
Text
id pubmed-7576763
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75767632020-10-21 Refining drug administration in a murine model of acute infection with Trypanosoma cruzi Gulin, Julián Ernesto Nicolás Bisio, Margarita García-Bournissen, Facundo Lab Anim Res Methodology BACKGROUND: In animal research, “refinement” refers to modifications of husbandry or experimental procedures to enhance animal well-being and minimize or eliminate pain and distress. Evaluation of drug efficacy in mice models, such as those used to study Trypanosoma cruzi infection, require prolonged drug administration by the oral route (e.g. for 20 consecutive days). However, the orogastric gavage method can lead to significant discomfort, upper digestive or respiratory tract lesions, aspiration pneumonia and even accidental death. The aim of this work was to evaluate the effect of two administration methods (conventional oral gavage vs. a refined method using a disposable tip and automatic pipette) on the efficacy of benznidazole in a murine model of T. cruzi infection. RESULTS: Both administration methods led to a rapid and persistent reduction in parasitaemia. Absence of T. cruzi DNA (evaluated by real-time PCR) in blood, cardiac and skeletal muscle confirmed that treatment efficacy was not influenced by the administration method used. CONCLUSIONS: The proposed refined method for long-term oral drug administration may be a suitable strategy for assessing drug efficacy in mice models of Chagas disease and can be applied to similar murine infection models to reduce animal discomfort. BioMed Central 2020-10-20 /pmc/articles/PMC7576763/ /pubmed/33094096 http://dx.doi.org/10.1186/s42826-020-00071-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Methodology
Gulin, Julián Ernesto Nicolás
Bisio, Margarita
García-Bournissen, Facundo
Refining drug administration in a murine model of acute infection with Trypanosoma cruzi
title Refining drug administration in a murine model of acute infection with Trypanosoma cruzi
title_full Refining drug administration in a murine model of acute infection with Trypanosoma cruzi
title_fullStr Refining drug administration in a murine model of acute infection with Trypanosoma cruzi
title_full_unstemmed Refining drug administration in a murine model of acute infection with Trypanosoma cruzi
title_short Refining drug administration in a murine model of acute infection with Trypanosoma cruzi
title_sort refining drug administration in a murine model of acute infection with trypanosoma cruzi
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576763/
https://www.ncbi.nlm.nih.gov/pubmed/33094096
http://dx.doi.org/10.1186/s42826-020-00071-z
work_keys_str_mv AT gulinjulianernestonicolas refiningdrugadministrationinamurinemodelofacuteinfectionwithtrypanosomacruzi
AT bisiomargarita refiningdrugadministrationinamurinemodelofacuteinfectionwithtrypanosomacruzi
AT garciabournissenfacundo refiningdrugadministrationinamurinemodelofacuteinfectionwithtrypanosomacruzi